Proteomics of rat biological fluids - The tenth anniversary update

Journal of Proteomics

Volumn 75, Issue 11, 2012, Pages 3113-3128

  Gianazza, Elisabetta ^a   Wait, Robin ^c   Eberini, Ivano ^a   Sensi, Cristina ^a   Sironi, Luigi ^a,b   Miller, Ingrid ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

Animal models of disease; Broncho alveolar lavage fluid; Cerebrospinal fluid; Serum; Urine

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; BENZENE; C REACTIVE PROTEIN; CALGRANULIN A; CISPLATIN; CYCLOSPORIN A; EZRIN; FENOFIBRATE; FETUIN A; FETUIN B; FORMALDEHYDE; GLYCOPROTEIN; HAPTOGLOBIN; IBUPROFEN; INDOMETACIN; LIPOPOLYSACCHARIDE; MEPRIN; MOESIN; NICOTINE; PARACETAMOL; PENTOXIFYLLINE; PREALBUMIN; PUROMYCIN; ROSUVASTATIN; STREPTOZOCIN; TAMM HORSFALL GLYCOPROTEIN; TERUTROBAN; TRYPSIN INHIBITOR; VALSARTAN;

BODY FLUID; BRAIN ISCHEMIA; CARCINOGENESIS; CEREBROSPINAL FLUID; CHRONIC INFLAMMATION; CYANOCOBALAMIN DEFICIENCY; DISEASE COURSE; EXPERIMENTAL MODEL; HEMATOLOGIC MALIGNANCY; HYPEROXALURIA; LUNG LAVAGE; METABOLIC DISORDER; MICROALBUMINURIA; NEPHROLITHIASIS; NEPHROTOXICITY; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SEPSIS; SERUM; STROKE; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; TRAUMATIC BRAIN INJURY; URINE;

ANIMALS; BODY FLUIDS; DISEASE MODELS, ANIMAL; FEMALE; MALE; PROTEOMICS; RATS; SEX CHARACTERISTICS;

ANIMALIA; RATTUS;

EID: 84861687257     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.03.053     Document Type: Review

References (116)

1. Gianazza E., Eberini I., Villa P., Fratelli M., Pinna C., Wait R., et al. Monitoring the effects of drug treatment in rat models of disease by serum protein analysis. J Chromatogr B 2002, 771:107-130.
2. Gianazza E., Vegeto E., Eberini I., Sensi C., Miller I. Neglected markers: Altered serum proteome in murine models of disease. Proteomics 2012, 12:691-707.
3. Wait R., Chiesa G., Parolini C., Miller I., Begum S., Brambilla D., et al. Reference maps of mouse serum acute-phase proteins: changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes. Proteomics 2005, 5:4245-4253.
4. Miller I., Haynes P., Gemeiner M., Aebersold R., Manzoni C., Lovati M.R., et al. Proteins of rat serum: II. Influence of some biological parameters on the 2-DE pattern. Electrophoresis 1998, 19:1493-1500.
5. Miller I., Haynes P., Eberini I., Gemeiner M., Aebersold R., Gianazza E. Proteins of rat serum: III. Gender-related differences in protein concentration under baseline conditions and upon experimental inflammation. Electrophoresis 1999, 20:836-845.
6. Eberini I., Agnello D., Miller I., Villa P., Fratelli M., Ghezzi P., et al. Proteins of rat serum: V. Adjuvant arthritis and its modulation by non steroidal antiinflammatory drugs. Electrophoresis 2000, 21:2170-2179.
7. Eberini I., Miller I., Zancan V., Bolego C., Puglisi L., Gemeiner M., et al. Proteins of rat serum: IV. Time-course of acute phase protein expression and its modulation by indomethacin. Electrophoresis 1999, 20:846-853.
8. Sironi L., Tremoli E., Miller I., Guerrini U., Calvio A.M., Eberini I., et al. Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics. Stroke 2001, 32:753-760.
9. Banfi C., Sironi L., De Simoni G., Gelosa P., Barcella S., Perego C., et al. Pentoxifylline prevents spontaneous brain ischemia in stroke-prone rats. J Pharmacol Exp Ther 2004, 310:890-895.
10. Sironi L., Gelosa P., Guerrini U., Banfi C., Crippa V., Brioschi M., et al. Anti-inflammatory effects of AT1 receptor blockade provide end-organ protection in stroke-prone ratsindependently from blood pressure fall. J Pharmacol Exp Ther 2004, 311:989-995.
11. Sironi L., Gianazza E., Gelosa P., Guerrini U., Nobili E., Gianella A., et al. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Arterioscler Thromb Vasc Biol 2005, 25:598-603.
12. Gianazza E., Veber D., Eberini I., Buccellato F.R., Mutti E., Sironi L., et al. Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid. Biochem J 2003, 374:239-246.
13. Haynes P., Miller I., Aebersold R., Gemeiner M., Eberini I., Lovati M.R., et al. Proteins of rat serum: I. Establishing a reference 2-DE map by immunodetection and microbore high performance liquid chromatography-electrospray mass spectrometry. Electrophoresis 1998, 19:1484-1492.
14. Eberini I., Miller I., Gemeiner G., Haynes P., Aebersold R., Puglisi L., et al. A Web site for the Rat Serum Protein Study Group. Electrophoresis 1999, 20:3599-3602.
15. Wait R., Gianazza E., Eberini I., Sironi L., Dunn M.J., Gemeiner M., et al. Proteins of rat serum, urine and cerebrospinal fluid: VI. Further protein identifications and interstrain comparison. Electrophoresis 2001, 22:3043-3052.
16. Gianazza E., Astrua-Testori S., Giacon P., Righetti P.G. An improved protocol for 2D maps of serum proteins with immobilized pH gradients in the first dimension. Electrophoresis 1985, 6:332-339.
17. Ballerio R., Gianazza E., Mussoni L., Miller I., Gelosa P., Guerrini U., et al. Gender differences in endothelial function and inflammatory markers along the occurrence of pathological events in stroke-prone rats. Exp Mol Pathol 2007, 82:33-41.
18. Wait R., Begum S., Brambilla D., Carabelli A.M., Conserva F., Rocco Guerini A., et al. Redox options in two-dimensional electrophoresis. Amino Acids 2005, 28:239-272.
19. Piubelli C., Cecconi D., Astner H., Caldara F., Tessari M., Carboni L., et al. Proteomic changes in rat serum, polymorphonuclear and mononuclear leukocytes after chronic nicotine administration. Proteomics 2005, 5:1382-1394.
20. Follettie M.T., Pinard M., Keith J.C., Wang L., Chelsky D., Hayward C., et al. Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology 2006, 147:714-723.
21. Hinkelbein J., Feldmann R.E., Schubert C., Peterka A., Schelshorn D., Maurer M.H., et al. Alterations in rat serum proteome and metabolome as putative disease markers in sepsis. J Trauma 2009, 66:1065-1075.
22. Wyatt A.R., Yerbury J.J., Wilson M.R. Structural characterization of clusterin-chaperone client protein complexes. J Biol Chem 2009, 284:21920-21927.
23. Wyatt A.R., Wilson M.R. Identification of human plasma proteins as major clients for the extracellular chaperone clusterin. J Biol Chem 2011, 285:3532-3539.
24. Yerbury J.J., Rybchyn M.S., Easterbrook-Smith S.B., Henriques C., Wilson M.R. The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin. Biochemistry 2005, 44:10914-10925.
25. French K., Yerbury J.J., Wilson M.R. Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity. Biochemistry 2008, 47:1176-1185.
26. Zsila F. Inhibition of heat- and chemical-induced aggregation of various proteins reveals chaperone-like activity of the acute-phase component and serine protease inhibitor human alpha(1)-antitrypsin. Biochem Biophys Res Commun 2010, 393:242-247.
27. Zsila F. Chaperone-like activity of the acute-phase component human serum alpha 1-acid glycoprotein: inhibition of thermal- and chemical-induced aggregation of various proteins. Bioorg Med Chem Lett 2010, 20:1205-1209.
28. Wilson M.R., Yerbury J.J., Poon S. Potential roles of abundant extracellular chaperones in the control of amyloid formation and toxicity. Mol Biosyst 2008, 4:42-52.
29. Marshall T., Williams K.M., Vesterberg O. A comparison of two-dimensional gel electrophoresis methods for analysis of rat serum proteins following dimethylformamide exposure. Electrophoresis 1985, 6:392-398.
30. Zastrow G., Günther S., Postel W., Görg A., Diehl H.A., Jansen E.H.J.M. Serum proteins of rats exposed to organic solvents examined by horizontal two-dimensional electrophoresis with immobilized pH gradient in the first dimension. Electrophoresis 1990, 11:655-657.
31. Merrick B.A., Bruno M.E., Madenspacher J.H., Wetmore B.A., Foley J., Pieper R., et al. Alterations in the rat serum proteome during liver injury from acetaminophen exposure. J Pharmacol Exp Ther 2006, 318:792-802.
32. Shu Z., Pu X., Xiong X., Li Q., Wang Y., Zhai S. Differential expression of plasma proteins in cyclosporine A-induced rat acute nephrotoxicity. Biosci Biotechnol Biochem 2009, 73:592-598.
33. Rivera S., Ganz T. Animal models of anemia of inflammation. Semin Hematol 2009, 46:351-357.
34. Cohn S.M. Alternatives to blood in the 21st century. Crit Care 2004, 8(Suppl. 2):S15-S17.
35. 2 carriers: status in 2005. Curr Pharm Des 2005, 11:4099-4114.
36. Wang L.L., Li J.J., Zheng Z.B., Liu H.Y., Du G.J., Li S. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells. Eur J Pharmacol 2004, 502:1-10.
37. Wang Q., Jiang Y., Wu C., Zhao J., Yu S., Yuan B., et al. Study of a novel indolin-2-ketone compound Z24 induced hepatotoxicity by NMR-spectroscopy-based metabonomics of rat urine, blood plasma, and liver extracts. Toxicol Appl Pharmacol 2006, 215:71-82.
38. Wang Q., Zhao J., Yang B., Jiang Y., Wu C., Zheng Z., et al. Toxicological evaluation of z24, a novel indolin-2-ketone compound, in cultured human liver cells using toxicogenomic techniques. Int J Toxicol 2010, 29:380-390.
39. Wang Y., Yang B., Wu C., Zheng Z., Yuan Y., Hu Z., et al. Plasma and liver proteomic analysis of 3Z-3-[(1H-pyrrol-2-yl)-methylidene]-1-(1-piperidinylmethyl)-1,3-2H-indol-2-one-induced hepatotoxicity in Wistar rats. Proteomics 2010, 10:2927-2941.
40. Penno M.A., Bacic A., Colegate S.M., Hoffmann P., Michalski W.P. Identifying candidate serum biomarkers of exposure to tunicamycins in rats using two-dimensional electrophoresis. J Proteome Res 2009, 8:2812-2826.
41. Son W.K., Lee D.Y., Lee S.H., Joo W.A., Kim C.W. Analysis of proteins expressed in rat plasma exposed to dioxin using 2-dimensional gel electrophoresis. Proteomics 2003, 3:2393-2401.
42. Im H., Oh E., Mun J., Khim J.Y., Lee E., Kang H.S., et al. Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. J Proteome Res 2006, 5:1354-1366.
43. Lee H.J., Lee D.Y., Joo W.A., Sul D., Lee E., Kim C.W. Differential expression of proteins in rat plasma exposed to benzene. Proteomics 2004, 4:3498-3504.
44. Park S.Y., Phark S., Lee M., Zheng Z., Choi S., Won N.H., et al. Evaluation of plasma carcinogenic markers in rat hepatic tumors models induced by rat hepatoma N1-S1 cells and benzo[a]pyrene. Arch Pharm Res 2010, 33:247-255.
45. Li M., Ye B., Zhang Y., Chen H., Xia D., Liu M., et al. Proteomic analysis of serum in lung cancer induced by 3-methylcholanthrene. J Biomed Biotechnol 2009, 2009:397910.
46. Amacher D.E., Adler R., Herath A., Townsend R.R. Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. Clin Chem 2005, 51:1796-1803.
47. Walgren J.L., Mitchell M.D., Whiteley L.O., Thompson D.C. Identification of novel peptide safety markers for exocrine pancreatic toxicity induced by cyanohydroxybutene. Toxicol Sci 2007, 96:174-183.
48. Bandara L.R., Kelly M.D., Lock E.A., Kennedy S. A potential biomarker of kidney damage identified by proteomics: preliminary findings. Biomarkers 2003, 8:272-286.
49. Bertile F., Schaeffer C., Le Maho Y., Raclot T., Van Dorsselaer A. A proteomic approach to identify differentially expressed plasma proteins between the fed and prolonged fasted states. Proteomics 2009, 9:148-158.
50. Santos-Gonzalez M., Lopez-Miranda J., Perez-Jimenez F., Navas P., Villalba J.M. Dietary oil modifies the plasma proteome during aging in the rat. Age (Dordr) 2012, 34:341-358.
51. Santos-Gonzalez M., Gomez Diaz C., Navas P., Villalba J.M. Modifications of plasma proteome in long-lived rats fed on a coenzyme Q10-supplemented diet. Exp Gerontol 2007, 42:798-806.
52. Choi J.W., Wang X., Joo J.I., Kim D.H., Oh T.S., Choi D.K., et al. Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats. Proteomics 2010, 10:4386-4400.
53. Kruger A.J., Yang C., Tam S.W., Hinerfeld D., Evans J.E., Green K.M., et al. Haptoglobin as an early serum biomarker of virus-induced autoimmune type 1 diabetes in biobreeding diabetes resistant and LEW1.WR1 rats. Exp Biol Med (Maywood) 2010, 235:1328-1337.
54. Li R.X., Chen H.B., Tu K., Zhao S.L., Zhou H., Li S.J., et al. Localized-statistical quantification of human serum proteome associated with type 2 diabetes. PLoS One 2008, 3:e3224.
55. Kawano K., Hirashima T., Mori S., Natori T. OLETF (Otsuka Long-Evans Tokushima Fatty) rat: a new NIDDM rat strain. Diabetes Res Clin Pract 1994, 24:S317-S320. (Suppl.).
56. Matsumura T., Suzuki T., Kada N., Aizawa K., Munemasa Y., Nagai R. Differential serum proteomic analysis in a model of metabolic disease. Biochem Biophys Res Commun 2006, 351:965-971.
57. Zhang S.X., Sun H., Sun W.J., Jiao G.Z., Wang X.J. Proteomic study of serum proteins in a type 2 diabetes mellitus rat model by Chinese traditional medicine Tianqi Jiangtang Capsule administration. J Pharm Biomed Anal 2010, 53:1011-1014.
58. Kim S.W., Hwang H.J., Kim H.M., Lee M.C., Shik Lee M., Choi J.W., et al. Effect of fungal polysaccharides on the modulation of plasma proteins in streptozotocin-induced diabetic rats. Proteomics 2006, 6:5291-5302.
59. Callow M.J., Redgrave T.G. Isoforms of rat apolipoproteins and changes induced by insulin deficiency and fasting. Biochim Biophys Acta 1993, 1168:271-279.
60. Linke T., Doraiswamy S., Harrison E.H. Rat plasma proteomics: effects of abundant protein depletion on proteomic analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 849:273-281.
61. Pan T.L., Wang P.W., Huang C.C., Goto S., Chen C.L. Expression, by functional proteomics, of spontaneous tolerance in rat orthotopic liver transplantation. Immunology 2004, 113:57-64.
62. Li S.Q., Yun J., Xue F.B., Bai C.Q., Yang S.G., Que H.P., et al. Comparative proteome analysis of serum from acute pulmonary embolism rat model for biomarker discovery. J Proteome Res 2007, 6:150-159.
63. Zagorski J., Marchick M.R., Kline J.A. Rapid clearance of circulating haptoglobin from plasma during acute pulmonary embolism in rats results in HMOX1 up-regulation in peripheral blood leukocytes. J Thromb Haemost 2010, 8:389-396.
64. Mohottalage S., Vincent R., Kumarathasan P. Assessment of suitability of magnetic beads for purification of rat plasma in proteomic analyses by matrix-assisted laser desorption ionization-time-of-flight MS. J AOAC Int 2009, 92:1652-1657.
65. Collins B.C., Sposny A., McCarthy D., Brandenburg A., Woodbury R., Pennington S.R., et al. Use of SELDI MS to discover and identify potential biomarkers of toxicity in InnoMed PredTox: a multi-site, multi-compound study. Proteomics 2010, 10:1592-1608.
66. Deng X.Y., Li W.R., Sun Y.W., Wei H.D., Jiang Y., He F.C. Exploring rat plasmatic proteomes: what triggered the liver regeneration?. Protein Pept Lett 2009, 16:698-705.
67. Carboni L., Becchi S., Piubelli C., Mallei A., Giambelli R., Razzoli M., et al. Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1037-1048.
68. Voshol H., Brendlen N., Muller D., Inverardi B., Augustin A., Pally C., et al. Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. J Proteome Res 2005, 4:1192-1199.
69. Cheng J., Zhou L., Jiang J.W., Qin Y.S., Xie H.Y., Feng X.W., et al. Proteomic analysis of differentially expressed proteins in rat liver allografts developed acute rejection. Eur Surg Res 2010, 44:43-51.
70. Suckow M.A., Weisbroth S.H., Franklin C.L. The laboratory rat 2005, Academic Press, New York. 2nd edition.
71. Walls A.F., Longbottom J.L. Quantitative immunoelectrophoretic analysis of rat allergen extracts. I. Antigenic characterisation of fur, urine, saliva and other rat-derived materials. Allergy 1983, 38:419-431.
72. Walls A.F., Longbottom J.L. Quantitative immunoelectrophoretic analysis of rat allergen extracts. II. Fur, urine and saliva studied by crossed radio-immunoelectrophoresis. Allergy 1983, 38:501-512.
73. Gordon S., Tee R.D., Taylor A.J. Analysis of rat urine proteins and allergens by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting. J Allergy Clin Immunol 1993, 92:298-305.
74. Bayard C., Holmquist L., Vesterberg O. Purification and identification of allergenic alpha (2u)-globulin species of rat urine. Biochim Biophys Acta 1996, 1290:129-134.
75. Southan C., Cutler P., Birrell H., Connell J., Fantom K.G., Sims M., et al. The characterisation of novel secreted Ly-6 proteins from rat urine by the combined use of two-dimensional gel electrophoresis, microbore high performance liquid chromatography and expressed sequence tag data. Proteomics 2002, 2:187-196.
76. Malard V., Gaillard J.C., Berenguer F., Sage N., Quemeneur E. Urine proteomic profiling of uranium nephrotoxicity. Biochim Biophys Acta 2009, 1794:882-891.
77. Thongboonkerd V., Klein J.B., Arthur J.M. Proteomic identification of a large complement of rat urinary proteins. Nephron Exp Nephrol 2003, 95:e69-e78.
78. Moon P.G., Hwang H.H., Boo Y.C., Kwon J., Cho J.Y., Baek M.C. Identification of rat urinary glycoproteome captured by three lectins using gel and LC-based proteomics. Electrophoresis 2008, 29:4324-4331.
79. Lee R.S., Monigatti F., Lutchman M., Patterson T., Budnik B., Steen J.A., et al. Temporal variations of the postnatal rat urinary proteome as a reflection of systemic maturation. Proteomics 2008, 8:1097-1112.
80. Jones W.T., Waterhouse R.L., Resnick M.I. The evaluation of urinary protein patterns in a stone-forming animal model using two-dimensional polyacrylamide gel electrophoresis. J Urol 1991, 145:868-874.
81. Holly M.K., Dear J.W., Hu X., Schechter A.N., Gladwin M.T., Hewitt S.M., et al. Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int 2006, 70:496-506.
82. Schlatzer D.M., Dazard J.E., Dharsee M., Ewing R.M., Ilchenko S., Stewart I., et al. Urinary protein profiles in a rat model for diabetic complications. Mol Cell Proteomics 2009, 8:2145-2158.
83. Wang Y., Chen Y., Zhang Y., Wu S., Ma S., Hu S., et al. Differential ConA-enriched urinary proteome in rat experimental glomerular diseases. Biochem Biophys Res Commun 2008, 371:385-390.
84. Cutler P., Bell D.J., Birrell H.C., Connelly J.C., Connor S.C., Holmes E., et al. An integrated proteomic approach to studying glomerular nephrotoxicity. Electrophoresis 1999, 20:3647-3658.
85. Aguiar M., Masse R., Gibbs B.F. Mass spectrometric quantitation of C-reactive protein using labeled tryptic peptides. Anal Biochem 2006, 354:175-181.
86. Gibbs A. Comparison of the specificity and sensitivity of traditional methods for assessment of nephrotoxicity in the rat with metabonomic and proteomic methodologies. J Appl Toxicol 2005, 25:277-295.
87. Mischak H., Espandiari P., Sadrieh N., Hanig J. Profiling of rat urinary proteomic patterns associated with drug-induced nephrotoxicity using CE coupled with MS as a potential model for detection of drug-induced adverse effects. Proteomics Clin Appl 2009, 3:1062-1071.
88. Boatman R.J., English J.C., Perry L.G., Fiorica L.A. Covalent protein adducts of hydroquinone in tissues from rats: quantitation of sulfhydryl-bound forms following single gavage or intraperitoneal administration or repetitive gavage administration. Chem Res Toxicol 2000, 13:861-872.
89. Labenski M.T., Fisher A.A., Monks T.J., Lau S.S. One-dimensional western blotting coupled to LC-MS/MS analysis to identify chemical-adducted proteins in rat urine. Methods Mol Biol 2011, 691:327-338.
90. Sharma M., Halligan B.D., Wakim B.T., Savin V.J., Cohen E.P., Moulder J.E. The urine proteome as a biomarker of radiation injury. Proteomics Clin Appl 2008, 2:1065-1086.
91. Dare T.O., Davies H.A., Turton J.A., Lomas L., Williams T.C., York M.J. Application of surface-enhanced laser desorption/ionization technology to the detection and identification of urinary parvalbumin-alpha: a biomarker of compound-induced skeletal muscle toxicity in the rat. Electrophoresis 2002, 23:3241-3251.
92. Smyth R., Lane C.S., Ashiq R., Turton J.A., Clarke C.J., Dare T.O., et al. Proteomic investigation of urinary markers of carbon-tetrachloride-induced hepatic fibrosis in the Hanover Wistar rat. Cell Biol Toxicol 2009, 25:499-512.
93. Parada C., Gato A., Bueno D. Mammalian embryonic cerebrospinal fluid proteome has greater apolipoprotein and enzyme pattern complexity than the avian proteome. J Proteome Res 2005, 4:2420-2428.
94. Zappaterra M.D., Lisgo S.N., Lindsay S., Gygi S.P., Walsh C.A., Ballif B.A. A comparative proteomic analysis of human and rat embryonic cerebrospinal fluid. J Proteome Res 2007, 6:3537-3548.
95. Siman R., McIntosh T.K., Soltesz K.M., Chen Z., Neumar R.W., Roberts V.L. Proteins released from degenerating neurons are surrogate markers for acute brain damage. Neurobiol Dis 2004, 16:311-320.
96. Suzuyama K., Shiraishi T., Oishi T., Ueda S., Okamoto H., Furuta M., et al. Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia. Brain Res Mol Brain Res 2004, 129:44-53.
97. Rite I., Arguelles S., Venero J.L., Garcia-Rodriguez S., Ayala A., Cano J., et al. Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration. J Neurosci Res 2007, 85:3607-3618.
98. Umstead T.M., Freeman W.M., Chinchilli V.M., Phelps D.S. Age-related changes in the expression and oxidation of bronchoalveolar lavage proteins in the rat. Am J Physiol Lung Cell Mol Physiol 2009, 296:L14-L29.
99. Signor L., Tigani B., Beckmann N., Falchetto R., Stoeckli M. Two-dimensional electrophoresis protein profiling and identification in rat bronchoalveolar lavage fluid following allergen and endotoxin challenge. Proteomics 2004, 4:2101-2110.
100. Lee Y.S., Chen P.W., Tsai P.J., Su S.H., Liao P.C. Proteomics analysis revealed changes in rat bronchoalveolar lavage fluid proteins associated with oil mist exposure. Proteomics 2006, 6:2236-2250.
101. Floros J., Phelps D.S., Kourembanas S., Taeusch H.W. Primary translation products, biosynthesis, and tissue specificity of the major surfactant protein in rat. J Biol Chem 1986, 261:828-831.
102. Shan L., Kawakami T., Asano S., Noritake S., Yoshimoto D., Yamashita K., et al. Inverse relationship between Sec14l3 mRNA/protein expression and allergic airway inflammation. Eur J Pharmacol 2009, 616:293-300.
103. Ahn K.H., Kim S.K., Lee J.M., Jeon H.J., Lee D.H., Kim D.K. Proteomic analysis of bronchoalveolar lavage fluid obtained from rats exposed to formaldehyde. J Health Sci 2010, 56:287-295.
104. Carswell H.V., McBride M.W., Graham D., Dominiczak A.F., Macrae I.M. Mutant animal models of stroke and gene expression: the stroke-prone spontaneously hypertensive rat. Methods Mol Med 2005, 104:49-74.
105. Howells D.W., Porritt M.J., Rewell S.S., O'Collins V., Sena E.S., van der Worp H.B., et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab 2010, 30:1412-1431.
106. Sironi L., Guerrini U., Tremoli E., Miller I., Gelosa P., Lascialfari A., et al. Analysis of the pathological events at the onset of brain damage in stroke-prone rats: a magnetic resonance imaging and proteomic approach. J Neurosci Res 2004, 78:115-122.
107. Gelosa P., Ballerio R., Banfi C., Nobili E., Gianella A., Pignieri A., et al. Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction: comparison with aspirin and rosuvastatin. J Pharmacol Exp Ther 2010, 334:199-205.
108. Gelosa P., Banfi C., Gianella A., Brioschi M., Pignieri A., Nobili E., et al. Peroxisome proliferator-activated receptor alpha agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats. J Pharmacol Exp Ther 2010, 335:324-331.
109. Devaraj S., Singh U., Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009, 55:229-238.
110. Genest J. C-reactive protein: risk factor, biomarker and/or therapeutic target?. Can J Cardiol 2010, 26(Suppl. A):41A-4A.
111. Pieper R., Gatlin C.L., Makusky A.J., Russo P.S., Schatz C.R., Miller S.S., et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 2003, 3:1345-1364.
112. Pieper R., Gatlin C.L., McGrath A.M., Makusky A.J., Mondal M., Seonarain M., et al. Characterization of the human urinary proteome: a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots. Proteomics 2004, 4:1159-1174.
113. Sennels L., Salek M., Lomas L., Boschetti E., Righetti P.G., Rappsilber J. Proteomic analysis of human blood serum using peptide library beads. J Proteome Res 2007, 6:4055-4062.
114. Castagna A., Cecconi D., Sennels L., Rappsilber J., Guerrier L., Fortis F., et al. Exploring the hidden human urinary proteome via ligand library beads. J Proteome Res 2005, 4:1917-1930.
115. Mouton-Barbosa E., Roux-Dalvai F., Bouyssie D., Berger F., Schmidt E., Righetti P.G., et al. In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol Cell Proteomics 2010, 9:1006-1021.
116. Candiano G., Santucci L., Bruschi M., Petretto A., D'Ambrosio C., Scaloni A., et al. "Cheek-to-cheek" urinary proteome profiling via combinatorial peptide ligand libraries: a novel, unexpected elution system. J Proteomics 2012, 75:796-805.